Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ABSI
ABSI
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABSI News
11 Stocks That Have Plummeted and Appear to Be Good Investment Opportunities
6d ago
Barron's
Salesforce Shares and 10 Other Stocks That Have Plummeted and Appear to Be Good Investments
6d ago
Barron's
ARK Genomic Revolution ETF Falls 2.5%, Personalis Drops 9.8%
Jan 08 2026
NASDAQ.COM
Absci to Present AI Drug Innovations at 44th J.P. Morgan Healthcare Conference
Dec 16 2025
Globenewswire
Aleen Inc. Advances AI Platform for Personal Wellness Insights
Dec 12 2025
Newsfilter
Aleen Inc. Advances AI Wellness Platform for Personal Health Insights
Dec 12 2025
PRnewswire
Absci Unveils ABS-201 Antibody to Promote Human Hair Growth
Dec 11 2025
Newsfilter
Post-Market Surge: Stoke Therapeutics, Alpha Tau Medical, and Compass Pathways Top Biotech Gainers
Dec 10 2025
NASDAQ.COM
Absci Initiates ABS-201 Clinical Trial with Interim Data Expected in Mid-2026
Dec 04 2025
Globenewswire
Transcript of Absci (ABSI) Earnings Call for Q3 2025
Nov 13 2025
NASDAQ.COM
Major Stocks Including Ardent Health, KinderCare Learning, and Ibotta Decline in Thursday's Pre-Market Trading
Nov 13 2025
Benzinga
Absci's Earnings Outlook for Q3 2025
Nov 11 2025
SeekingAlpha
Absci Rises Following Speedy Clinical Trial Progress
Oct 15 2025
SeekingAlpha
Synopsys Analyst Starts Coverage with a Bearish Outlook; Check Out the Top 5 Initiations for Thursday
Oct 02 2025
Benzinga
Absci surges after J.P. Morgan initiates coverage with a Buy rating ahead of important catalyst
Oct 02 2025
SeekingAlpha
Absci Enhances AI-Driven Drug Discovery Through Partnership with Oracle and AMD
Sep 11 2025
Benzinga
Show More News
